The global Plasma Fractionation Market is experiencing robust growth driven by rising demand for plasma-derived therapies and increasing prevalence of chronic and rare diseases. The market size was over USD 36.95 billion in 2025 and is projected to exceed USD 80.51 billion by 2035, expanding at a CAGR of over 8.1% during the forecast period (2026–2035).
The sustained growth is supported...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
